A research agenda focusing on breakthrough infections, reinfections, severity, and sequelae is needed to inform clinical practice when COVID-19 emphasis shifts from eradication to living with the disease.
Westyn Branch-Elliman, MD, MMSc
Advertisement
Westyn Branch-Elliman, MD, MMSc, is an infectious disease physician and a clinician investigator at VA Boston Healthcare System. She is affiliated with Harvard Medical School.
Articles by Westyn Branch-Elliman, MD, MMSc
In the age of COVID-19, providers caring for patients with emerging diseases do not rely entirely on clinical guidelines, but also consult online resources that are updated more frequently. This needed integration helps providers adapt to the best-available evidence into bedside care when guidance is lacking.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Oral Carbapenem Tebipenem HBr Demonstrates Non-Inferiority to IV Therapy in Phase III PIVOT-PO Trial
2
Introducing Cefiderocol Earlier in Difficult-to-Treat-Infections
3
New Data Highlight Adult Pneumococcal Serotypes with Greater Antibiotic Resistance and Disease Burden Covered by Merck’s Vaccine
4
Lori Handy, MD, MSCE, Discusses New Era of Dynamic, Trust-Based Health Communication
5
